Index of reports
> Cases with Hepatic Function Abnormal (4)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Invirase (Saquinavir) where reactions include hepatic function abnormal. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Invirase side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Hepatic Function Abnormal, Cardiac Failure
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Invirase
Dosage: divided dose requency u
Administration route: Oral
Indication: HIV Infection
Start date: 2006-10-26
Isentress
Dosage: divided dose frequency unknown
Administration route: Oral
Indication: HIV Infection
Start date: 2008-07-31
End date: 2011-08-07
Kaletra
Dosage: divided dose frequency unknown
Administration route: Oral
Start date: 2004-08-31
End date: 2006-09-21
Kaletra
Dosage: divided dose frequency unknown
Administration route: Oral
Start date: 2006-10-26
End date: 2011-07-07
Kaletra
Dosage: divided dose frequency unknown
Administration route: Oral
Indication: HIV Infection
Start date: 2002-09-03
End date: 2004-08-04
Other drugs received by patient: Halcion
Possible Invirase side effects in male
Reported by a physician from Japan on 2012-07-06
Patient: male
Reactions: Hepatic Function Abnormal, Cardiac Failure
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Didanosine
Administration route: Oral
Indication: HIV Infection
Start date: 2006-10-26
Invirase
Administration route: Oral
Indication: HIV Infection
Start date: 2006-10-26
Lopinavir and Ritonavir
Administration route: Oral
Indication: HIV Infection
End date: 2006-09-21
Lopinavir and Ritonavir
Administration route: Oral
Start date: 2006-10-26
Raltegravir
Administration route: Oral
Indication: HIV Infection
Other drugs received by patient: Ziagen; Halcion; Viread
Possible Invirase side effects in male
Reported by a physician from Japan on 2012-04-18
Patient: male
Reactions: Hepatic Function Abnormal, Cardiac Failure
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Invirase
Administration route: Oral
Indication: HIV Infection
Start date: 2006-10-26
Lopinavir and Ritonavir
Administration route: Oral
Indication: HIV Infection
Raltegravir
Administration route: Oral
Indication: HIV Infection
Other drugs received by patient: Halcion
Possible Invirase side effects in 46 year old male
Reported by a individual with unspecified qualification from Japan on 2012-04-13
Patient: 46 year old male
Reactions: Blood Alkaline Phosphatase Increased, Hepatic Function Abnormal, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Pericardial Effusion, Gamma-Glutamyltransferase Increased, Cardiac Failure, Aspartate Aminotransferase Increased, Pleural Effusion
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Invirase
Dosage: 2000 mg/daily/po
Administration route: Oral
Indication: HIV Infection
Start date: 2006-10-26
Isentress
Dosage: 800 mg/daily/po
Administration route: Oral
Indication: HIV Infection
Start date: 2008-07-31
Kaletra
Dosage: 4 dose/daily/po
Administration route: Oral
Indication: HIV Infection
Start date: 2006-10-26
Kaletra
Dosage: 6 dose/daily/po
Administration route: Oral
Indication: HIV Infection
Start date: 2002-09-03
End date: 2004-08-04
Kaletra
Dosage: 6 dose/daily/po
Administration route: Oral
Indication: HIV Infection
Start date: 2004-08-31
End date: 2006-09-21
Other drugs received by patient: Zerit; Halcion; Videx EC
|